Norwegian Company: "We Can Produce Bird-Flu Vaccine"
Posted on: Wednesday, 19 October 2005, 12:01 CDT
Norwegian company Bionor Immuno has claimed it could produce a bird-flu vaccine, which could prevent 80 per cent of sufferers from dying of the disease, in just over a year.
The company, which is based in Skien [town 60 miles/100 kilometres south west of Oslo], has been working on developing an HIV vaccine for several years and believes it can use the same technique for bird flu.
Company director Birger Soerensen told Norwegian radio that it was not necessary to wait until the existing bird-flu virus had mutated into one which could affect humans before development work began.
The company will now present a proposed development project to the Norwegian Institute of Public Health.
Soerensen said developing the vaccine would cost 10-15m kroner [about 1.5-2.3m dollars] before production began.
Source: BBC Monitoring European
Related Articles
- Homeless Die in Poland of Bird-Flu Vaccine
- GelVac(TM) Nasal Powder H5N1 (Bird Flu) Influenza Vaccine Passes Preclinical Toxicology Studies
- Bird Flu Oral Vaccine Licensed By MDM Group
- U.S. Making Progress on Bird Flu, but Vaccine Supplies Are Inadequate
- China Exclusive: China Prepare to Mass-Produce Bird Flu Vaccine Forhumans
- China Preparing to Mass-Produce Bird Flu Vaccine for Humans
- Chinese Minister Says Bird Flu Human Vaccine Ready for Clinical Tests
- BIRD FLU: Vaccines Are Useless Against This Virus
- 3 Hungary Officials Get Bird Flu Vaccine
- Asian Countries Agree to Set Up Bird Flu Vaccine Center
 |
 |
User Comments (0)
RSS Feeds